Declares Dividend of $0.50 per share for Q4 2025, Marking Highest Dividend Since 2022 and 26th Consecutive Quarterly Dividend Generated Q4 Adj. EBITDA of $42.0 Million and TCE of $20,064, Representing Highest Levels Since 2022 Two Newcastlemax Vessels Expected to be Delivered in Q1 2026, Further Enhancing Earnings Power and Dividend Capacity NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months and twelve months ended December 31, 2025. Fourth Quarter 2025 and Year-to-Date HighlightsDividendDeclared a $0.50 per share dividend for Q4 2025, highest level since Q4 2022 26th consecutive quarterly dividendCumulative...

Sales and adjusted EBITDA in-line with Company expectations, reiterates full year guide 80 underperforming stores closed during Q1 2026 Improved inventory efficiency with ~23% reduction year-over-year PHOENIX, Feb. 17, 2026 (GLOBE NEWSWIRE) — Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its financial results for the fiscal first quarter 2026. Jason McDonell, Chief Executive Officer, said, “Leslie’s transformation journey is gaining momentum as we execute with precision and urgency. Our first quarter results met our expectations, and we’ve made meaningful optimization progress across stores, distribution, SKUs, and costs. While Q1 and Q2 historically represent approximately...

Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY2025 annual resultsRevenue up 4% Improved results Stronger growth potentialCondensed consolidated income statement 20252024Pro forma*  2024ReportedIn thousands of euros  Revenue 12,430 11,950   11,950Cost of sales -3,783 -3,699   -3,699Gross margin 8,647 8,250   8,250% of revenue 69,6% 69,0%   69%Net operating expenses -10,780 -10,227   -9,131Of which external expenses -3,967 -3,522   -3,646Of which personnel expenses -4,600 -4,890   -4,890         Of which other op. income and expenses -1,436 -920   -358Of which dep., amort., and provisions -777 -895   -818Of which research/innovation tax credits , ,   582Operating income/(loss) -2,133 -1,977   -881Financial income/(expense) -316 -2,464   -2,464Non-recurring income/(expenses) 62 ,   -514Corporate...

Management Board of Baltic Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the twelve months of 2025. The Fund reports Q4 2025 and full year 2025 unaudited results in the spirit of fresh start under new ownership of the Management Company, strengthened organization, and at the same time communicates a decision to proceed with the secondary public offering of new units. The Fund generated a total of EUR 15,098 thousand of rental income during 2025. Due to significant vacancies across the portfolio (13.8% at the end of 2025), the limitations of rental contracts, and the write-offs of old debts, the total volume of property costs not recovered from the tenants amounted to EUR 3,435 thousand during the year, thus resulting in the Net Operating Income (NOI) of EUR 11,663 thousand. Excluding...

TOPDON USA teamTOPDON USA announced that 2025 marked a 70% sales increase for the company’s U.S. operations over 2024.ROCKAWAY, NEW JERSEY, Feb. 17, 2026 (GLOBE NEWSWIRE) — TOPDON USA (https://www.topdon.us/),  a leading provider of cutting-edge diagnostic tools and technology solutions for automotive repair professionals and DIYers, announced today that 2025 marked a 70% sales increase for the company’s U.S. operations over 2024. Driven by technology innovation, TOPDON USA introduced several DIY, prosumer, and heavy-duty products last year, including the ArtiDiag EU, RLink J2534, TP58, V3000, UltraDiag Moto, V1200Air, ArtiDiag HD, TS004 Pro, and BT600Plus. TOPDON USA also invested in multiple non-profit and auto education programs across the country to support the development and help secure the future of the automotive...

SINGAPORE, Feb. 17, 2026 (GLOBE NEWSWIRE) — Enigmatig Limited (NYSE American: EGG) (“Enigmatig” or the “Company”), a global business enabler supporting companies expanding across borders, today announced audited financial results for the fiscal year ended September 30, 2025. Revenue increased 12.2% year over year, with gross margin expanding to 68.8% and a strengthened balance sheet following the Company’s NYSE American listing. The Company also announced that it has filed its annual report on Form 20-F for the fiscal year ended September 30, 2025 with the U.S. Securities and Exchange Commission. Fiscal Year 2025 Financial Highlights● Total corporate services income increased by 12.2% to US$4.5 million for fiscal year 2025, compared with US$4.0 million for fiscal year 2024.● Cost of sales was US$1.4 million for fiscal year...

Fourth Quarter 2025 Net Revenues of $6.5 Million, Gross Profit of $3.3 Million and Gross Margin of 51.2% Net Revenue Increase of 102% and Gross Margin Increase of 169% as Compared to Q4 of the Prior Year Cash flow positive business operations for the quarter. REDMOND, Wash., Feb. 17, 2026 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, today reported its financial and operational results for the fourth quarter ended December 31, 2025. Q4 2025 Financial HighlightsNet revenues for the quarter ended December 31, 2025, were $6.5 million.Gross profits for the quarter ended December 31, 2025, were $3.3 million.Gross margin percentage was 51.2% for the quarter ended December 31, 2025. Higher margins were...

Second Quarter Performance Driven by Successful Deployment of Treasury Operations; Reflecting Commitment to Strategic Focus on Leveraging Litecoin Holdings Complemented by Disciplined Capital Allocation SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced financial results for the fiscal 2026 second quarter ended December 31, 2025. During the second quarter, the Company successfully launched its strategic initiative to transform its LTC holdings into a productive reserve asset, utilizing covered call options while also implementing a $25 million stock repurchase program. “The second quarter marked a pivotal shift in our evolution. We moved from simply accumulating...

Transformational Quarter Positions Company for Next Phase of Strong Growth SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced financial results for its second quarter fiscal 2026 ended December 31, 2025, and provided an update on transformational strategic initiatives that are positioning the Company as an integrated energy storage platform serving residential, commercial & industrial (C&I), and utility-scale markets. Management Commentary “This was a transformational quarter that sets NeoVolta up for the next phase of strong growth and positions us to capitalize on the massive market opportunity ahead,” said Ardes Johnson, Chief Executive...

Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026 Additional European launches expected in 2026 Type A meeting request submitted to the U.S. Food and Drug Administration for ONS-5010ISELIN, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for the first quarter fiscal year 2026 and provided a corporate update. “LYTENAVA™ (bevacizumab gamma) is demonstrating increasing adoption in Europe following our initial launches, with growing demand and quarter-over-quarter unit sales growth,” said Bob Jahr, Chief Executive Officer of Outlook Therapeutics. “Building...